维普中文期刊产品整合服务
345篇 您的检索式:作者名="Sledge"
    题名 作者 年代 出处 被引量
1Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis显示文摘Henry Buchwald Rhonda Estok Kyle Fahrbach Deirdre Banel Michael D. Jensen Walter J. Pories John P. Bantle Isabella Sledge 2009The American Journal of Medicine2009,,3:2
2Microfracture techniques in the treatment of osteochondral injuries 显示文摘Sledge SL 2001Clin sports Med2001,20,:1
3Teatment of thoracolumbar burst fractures without neurologic deficit by indirect reduction and posterior instrumentation : bisegmental stabilization with monosegmental fusion 显示文摘Muller U Berlmann U Sledge J 2007Eur Spine2007,6,6:1
4Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial(E1193) 显示文摘Sledge GW Neuberg D Bernardo P 2003J Clin Oncol2003,21,4:1
5Irreducible dislocations of the cervical spine with a prolapsed disc:preliminary results from a treatment technique显示文摘ALLRED CD SLEDGE JB 2001Spine2001,26,:1
6Angiogenesis and antiangiogenic therapy显示文摘 Miller K D 2002Curr ProblCaacer2002,26,1:1
7Association of polymorphisms of angiogenesis genes with breast cancer显示文摘Schneider BP Radovich M Sledge GW 2007Breast Cancer Res Treat2007,111,:1
8Exploiting the hallmarks of cancer: the future conquest of breast cancer显示文摘Sledge G Miller K 2003Eur J Cancer2003,39,12:1
9Treatment of thoraco- lumbar burst fractures without neumlogic deficit by indirect re- duction and posterior instrumentation: bisegmental stabilization with monosegmental fusion显示文摘Muller U Bedemann U Sledge J 1999Eur Spine J1999,8,4:1
10Phase Ⅲ trial of doxorubicin vs paclitaxel vs doxorubicin + paclitaxel as first- line therapy for metastatic cancer: an intergroup trial显示文摘Sledge G N Neuberg D Ingle S 1997J Clin Oncol1997,16,:1
11Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production显示文摘Starnes T Robertson MJ Sledge G 2001J Immunol2001,167,8:1
12Phase Ⅲ trial of doxo- rubicin, paclitaxel, and the combination of doxorubicin and pacli- taxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (El193) 显示文摘Sledge G Neuberg D Bermardo P 2003J Clin Oncol2003,21,4:1
13Medicago truncatula EST-SSRs reveal cross-species genetic markers for Medicago spp显示文摘Eujayl I Sledge M K Wang L 2004Theoretical and Applied Genetics2004,108,3:1
14A comparison of the accuracy of two minimally invasive breast biopsy methods:a systematic literature review and meta-analysis显示文摘Fahrbach K Sledge I Cella C 0,,02:1
15Treatment of thoracolumbar burst fractures without neurologic deficit by indirect reduction and posterior instrumentation:bisegmental stabilization with monosegmental fusion显示文摘Müller U Berlemann U Sledge J 1999Eur Spine J1999,10,8:1
16Redefining the target chemotherapeutics as antiangiogenics 显示文摘Miller KD Sweeney CJ Sledge GW 2001J Clln Oneol2001,19,4:1
17Treatment of thoracolumbar burst fractures without neurologic deficit by indirect reduction and posterior instrumentation:bisegmental stabilization with monosegmental fusion显示文摘Mul er U Berlemann U Sledge J 0,,04:1
18Experimental limb lengthening by epiphyseal distraction 显示文摘Sledge CB Nobel J 1978Clin Orthop1978,,136:1
19Redefining the target:chemotherapeutics as antiangiogenics显示文摘Miller KD Sweeney CJ Sledge GW 2001Clin Oncol2001,19,4:1
20Redefining the target : chemotherapeutics as antiangiogenics 显示文摘Miller KD Sweeney CJ Sledge GW 2001J Clin Oncol2001,19,4:1
返回顶部 每页显示:
共18页 首页 上一页 第1页 下一页 末页 /18 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费